Dyne Therapeutics, Inc. (DYN) stock
DYNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.01−0.98 (-5.45%)
Close on Nov 12, 2026Market cap $3.18BP/E –Yield –
Dyne Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Dyne Therapeutics's enterprise value was $2.08B on Nov 11, 2026, against $2.33B a year earlier. Over the last 5 years it ranged from -$74.72M to $3.84B, with a median of $723.26M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.08B | +4.2% |
| 2025 | Dec 31, 2025 | $2.00B | +19.4% |
| 2024 | Dec 31, 2024 | $1.67B | +154.4% |
| 2023 | Dec 29, 2023 | $657.76M | +86.1% |
| 2022 | Dec 30, 2022 | $353.46M | +72.7% |
| 2021 | Dec 31, 2021 | $204.62M | -64.4% |
| 2020 | Dec 31, 2020 | $575.42M | – |
See a number that looks wrong?